Sleem Bshara, Nassereldine Rakan, Ghazi Victor, Eid Karine, Hemdanieh Maya, Nassereddine Mohamad
Faculty of Medicine American University of Beirut Medical Center.
Department of Vascular Surgery American University of Beirut Medical Center.
Orthop Rev (Pavia). 2025 Mar 31;17:132223. doi: 10.52965/001c.132223. eCollection 2025.
Musculoskeletal injuries and degenerative conditions necessitate advanced regenerative solutions. Tissue engineering has emerged as a pivotal field in orthopedic care, particularly in vascularized bone and cartilage regeneration. This narrative review examines the latest advancements in vascular tissue engineering, including scaffold design, cell-based techniques, and growth factor delivery. A comprehensive literature search was conducted using PubMed, ScienceDirect, and Google Scholar, focusing on innovations and challenges in the field. Vascularized bone grafts (VBGs) outperform non-vascularized counterparts in promoting healing and integration. Advances in scaffold materials, such as smart scaffolds and hybrid biomaterials, enhance osteogenesis and angiogenesis. Cellular therapies, utilizing mesenchymal stem cells and induced pluripotent stem cells, synergistically improve vascularization and bone regeneration. Growth factors like VEGF and bone morphogenic protein (BMP-2), integrated with innovative delivery systems, enable sustained angiogenic stimulation and scaffold integration. While significant strides have been made, challenges persist in achieving full vascular integration and replicating native tissue architecture. Innovations in scaffold technology and vascular surgery techniques hold promise for transforming orthopedic tissue engineering and improving patient outcomes.
肌肉骨骼损伤和退行性疾病需要先进的再生解决方案。组织工程已成为骨科护理中的一个关键领域,特别是在血管化骨和软骨再生方面。这篇叙述性综述探讨了血管组织工程的最新进展,包括支架设计、基于细胞的技术和生长因子递送。使用PubMed、ScienceDirect和谷歌学术进行了全面的文献检索,重点关注该领域的创新和挑战。血管化骨移植(VBG)在促进愈合和整合方面优于非血管化骨移植。支架材料的进展,如智能支架和混合生物材料,可增强成骨作用和血管生成。利用间充质干细胞和诱导多能干细胞的细胞疗法可协同改善血管化和骨再生。像血管内皮生长因子(VEGF)和骨形态发生蛋白(BMP - 2)等生长因子与创新的递送系统相结合,能够实现持续的血管生成刺激和支架整合。尽管已经取得了重大进展,但在实现完全的血管整合和复制天然组织结构方面仍然存在挑战。支架技术和血管外科技术的创新有望改变骨科组织工程并改善患者预后。